Ask Eva: biopharma's market trends in 2023

Optimum Perspectives
07/09/2023 14 min Episodio 9
Ask Eva: biopharma's market trends in 2023

Listen "Ask Eva: biopharma's market trends in 2023 "

Descargar episodio Ver en sitio original

Episode Synopsis

Episode 9 of Optimum Perspectives Podcast features Optimum's Richard Staines and Eva Haas, who discuss the hot areas for investment in the shifting biotech market – including antibody-drug conjugates, smart radiotherapies, mRNA and immune-oncology. Want us to explore a topic further? Let us know! Hosted on Acast. See acast.com/privacy for more information.

More episodes of the podcast Optimum Perspectives

Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease 05/08/2025
Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025 25/06/2025
Stronger together: changing the future of muscle wasting condition 28/02/2025
How bioengineered spider silk-based proteins are changing the world 06/02/2025
How to have a perfect IPO on NASDAQ 23/01/2025
Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers 27/11/2024
Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer 21/11/2024
DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology 05/11/2024
SpliceBio: Celebrating progress in ophthalmology research on World Sight Day 10/10/2024
Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine 12/09/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA